80 results
Page 2 of 4
6-K
EX-99.3
uomm0qvvmv9hm
10 May 23
Current report (foreign)
7:27am
S-8
EX-5.1
uxv1zpl
6 Apr 23
Registration of securities for employees
4:24pm
6-K
fr19kgif5yj5oii5
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
fiz0xq02rat32ar
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K/A
EX-99.1
n2u4ekl2
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.1
87c67
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
52bsg 1er
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-5.2
12wkqhdcelag1 al
30 Sep 22
Current report (foreign)
4:24pm
6-K
EX-5.1
xr18 lkaf136
30 Sep 22
Current report (foreign)
4:24pm
424B7
6ehettc kzw7err
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-99.1
go2u3f91nyg
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
6-K
EX-5.1
u93m7u0e6shb4jjcgtj
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
pf5 cb5l4d3
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
sgvpqy
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.2
l3ft7aq7cd lgboo
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.1
ky2ijig123y
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.1
6hz6f
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.3
xern elpqk
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
asf j23vbz
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
7owf1
20 Jul 22
Securities Purchase Agreement
4:06pm